Didactic Webinar Series

Fellowship WebinarThe ACTRIMS Didactic Webinar Series is offered nationally to neuroimmunology and MS fellows beginning in August 2020.  An expert lecturer will present on niche topics to increase the educational yield for trainees. This series provides a forum for trainees to engage with advanced faculty on a scheduled basis.

Program

The Didactic Webinar Series will be held twice per month on Fridays from 4:00 – 5:00 PM ET. 

Goals:
  1. To use a virtual platform to provide national didactics on high-yield niche topics in neuroimmunology 
  2. To increase comfort levels among neuro-immunology trainees on high-yield niche topics in neuroimmunology
  3. To provide fellows with the opportunity for direct interactions with topic experts
  4. To facilitate discussion and networking among MS/Neuroimmunology trainees
Learning Objectives:
  1. Describe the tools underlying MS/Neuroimmunology evidence-based-practice, including trial design, lab-based testing and imaging
  2. Compare the pathogenic mechanisms underlying MS and other neuroimmunologic diseases
  3. Distinguish rare neuroimmune diseases and their mimics 
  4. Describe the issues affecting special populations (pediatric and advanced MS) and explain management strategies for these groups.
  5. Integrate cross-disciplinary tools to manage symptomatic concerns for MS and other neuroimmune diseases

CME Accreditation:
This webinar series has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Interstate Postgraduate Medical Association (IPMA) and ACTRIMS. Interstate Postgraduate Medical Association designations this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. A survey will be sent to all participants after each webinar to claim credit for that specific webinar. If you are unable to watch the webinars live, you may watch them on-demand and still receive a CME certificate.

Registration
If you are a neuroimmunology and/or MS fellow, contact Jordan Haag at [email protected] for registration information. 

Date Topic Speaker
08/07/2020 Clinical Trials Gary CutterUniversity of Alabama at Birmingham
08/21/2020 Neurosarcoidosis / CNS Vasculitis / NP-SLE / Neuro-Behcet's Jeffrey GelfandUniversity of California, San Francisco
09/04/2020 Lab Techniques & Tools for Understanding Ab-mediated Diseases Andrew McKeon, Mayo Clinic
09/18/2020 Autoimmune Myelitis and its Mimics Eoin Flanagan, Mayo Clinic
10/02/2020 B Cell and Autoantibody-mediated Pathogenesis in CNS Autoimmunity Jeffrey BennettUniversity of Colorado
10/16/2020 Caring for Advanced MS Francois Bethoux, Cleveland Clinic
11/06/2020 PML and Opportunistic Infections Joe Berger, University of Pennsylvania
11/20/2020 Basic Science of Remyelination Wendy MacklinUniversity of Colorado
12/04/2020 Advanced MRI Techniques [for MS/Neuroinflammation] Daniel Ontaneda, Cleveland Clinic
12/18/2020 Anti-NMDA Receptor Encephalitis and Mechanisms of Disease Josep DalmauUniversity of Barcelona,  University of Pennsylvania
New Year’s Day – January 1, 2021
01/15/2021 Hematopoietic and Mesenchymal Stem Cell Therapy for MS Jeffrey Cohen, Cleveland Clinic
02/05/2021 Progressive MS: Challenges in Finding and Demonstrating Effective Therapies Robert Fox, Cleveland Clinic
02/19/2021 Pediatric MS Brenda Banwell, Children’s Hospital of Philadelphia
ACTRIMS Forum 2021 – February 25-27, 2021
03/05/2021 Emerging Autoimmune Diseases Stacy Clardy, University of Utah
03/19/2021 Immuno-Biology of MS Anne Cross, Washington University
04/02/2021 Integrative Medicine and Cannabis Allen Bowling, NeuroHealth Institute, University of Colorado
AAN Annual Meeting – April 17-23, 2021
05/07/2021 Ethnicity & Diversity in the MS Experience Lilyana Amezcua, University of Southern California
CMSC Annual Meeting – June 2-5, 2021
06/18/2021 Urological Issues and Their Management in MS Nina Davis, Oregon Health and Science University


Funded in Part By

GenentechBiogen